however, many patients believe they were not adequately warned about this risk before taking them
The Bridge program is slated to run until the end of 2027, prompting providers to raise concerns about what will happen if the government does not extend it as people typically regain the weight they lost after stopping a GLP-1
10.1152/ajpendo.00283.2013 72
Read through this fact sheet on Flatulence from GLP-1 Injections to better understand why it happens, when it typically occurs, and what you can do about it
As an added bonus, medically eligible patients who purchase a CoolSculpting package will receive 12 weeks of microdosed Tirzepatide at no additional cost to complement their body transformation
Integrate GLP-1 coverage with robust, wraparound support, such as condition management programs, nutrition counseling, and wellness coaching